Browse Results

  • Division: : Cancer Center
  • Therapeutic Area: Leukemia, Lymphoma, and Myeloma


There are 22 clinical trial(s) matching your criteria.

Back

A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions for the Treatment of Keratoconjuctivitis Sicca in Patients with Chronic Ocular Graft versus Host Disease

Investigator: Victor Perez quinones

Institutional Protocol #: 20140195

National Clinical Trials Identifier: NCT02040623

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase: Phase II

Enrolling Since: 1/16/2015

Transplant Registry Reporting

Investigator: Martin Andreansky

Institutional Protocol #: 20057012

National Clinical Trials Identifier: N/A

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase:

Enrolling Since: 8/20/2012

Back